Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Image Guided Reirradiation of High-grade Glioma - a Phase I/II Dose Escalation Study

NCT02025231 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02025231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02025231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Image Guided Reirradiation of High-grade Glioma - a Phase I/II Dose Escalation Study
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2011
Completion date
April 30, 2015
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, malignant glioma